Bolt Biotherapeutics
BOLT----
Bolt Biotherapeutics (BOLT)
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies for the treatment of cancer. The company’s pipeline produ...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
- 52wk Low
- --
- Float Mkt Cap
- --
- Market Cap
- --
- P/ETTM
- --
- P/EDynamic
- --
- P/EStatic
- --
- EPSTTM
- --
- EPSDynamic
- --
- EPSStatic
- --
- BVPS
- --
- P/B
- --
- Circulating Supply
- --
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- --
- Min lot size
- --
- Currency
- --
Bolt Biotherapeutics Analyst Rating
View moreForecast & Rating
Oct 23, 2026Price forecast
$41.00553.91%
Forecast & RatingBuy
3analysts
- Strong buy66.67%
- Buy0.00%
- Hold33.33%
- Sell0.00%
- Strong sell0.00%
News
- Tip Ranks ·
Why Is Penny Stock Bolt Biotherapeutics (BOLT) Up 62% Today?
- benzinga_article ·
12 Health Care Stocks Moving In Friday's Intraday Session
- StockTitan ·
Bolt Biotherapeutics Announces Acquisition of Prana Therapies and $120 Million Concurrent Private Placement to Advance PRA-216 in Multiple High-Value Inflammatory Indications | BOLT Stock News
- Market Movers ·
Bolt Biotherapeutics soars 57% during regular trading
